Compare GKOS & CWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GKOS | CWST |
|---|---|---|
| Founded | 1998 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Environmental Services |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 5.9B |
| IPO Year | 2015 | 1997 |
| Metric | GKOS | CWST |
|---|---|---|
| Price | $103.96 | $88.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 8 |
| Target Price | ★ $133.07 | $117.50 |
| AVG Volume (30 Days) | 662.2K | ★ 848.1K |
| Earning Date | 01-01-0001 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | $507,442,000.00 | ★ $1,836,841,000.00 |
| Revenue This Year | $23.39 | $10.03 |
| Revenue Next Year | $27.46 | $6.48 |
| P/E Ratio | ★ N/A | $743.67 |
| Revenue Growth | ★ 32.33 | 17.95 |
| 52 Week Low | $73.16 | $82.22 |
| 52 Week High | $130.23 | $121.20 |
| Indicator | GKOS | CWST |
|---|---|---|
| Relative Strength Index (RSI) | 35.28 | 35.55 |
| Support Level | $81.54 | $85.31 |
| Resistance Level | $106.52 | $91.13 |
| Average True Range (ATR) | 3.58 | 3.69 |
| MACD | -1.81 | -0.37 |
| Stochastic Oscillator | 14.28 | 0.71 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.